Search suggestions
  • ph meter
  • balance
  • conductivity
  • counting platform scale
  • ind570
All Categories
  • All Categories
  • Products
  • Buy Online
  • Support
  • Expertise
  • Events & Webinars
  • Other
Filter
English
Home Expertise Library Reactive-to-Proactive Process Monitoring in Pharmaceutical Waters

Reactive-to-Proactive Process Monitoring in Pharmaceutical Waters

Meeting the evolving requirements of pharma waters with proactive process control

An On Demand Event hosted by American Pharmaceutical Review featuring a presentation from Jim Cannon, Head of OEM and Markets for Mettler Toledo Thornton and technical advisor to several Pharmacopeia organizations and active in ISPE and PDA groups. This free online event is for Microbiologists, Process Engineers, Pharmaceutical Water Owners, Quality Control and those interested in learning about the innovations and efficiencies of proactive, real time monitoring in pharmaceutical waters.

Better process control and transparency in pharma water process monitoring is necessary to provide quick risk assessment that can prevent undetected issues and production shutdowns. The ability to use continuous trending of water system data for measurements like TOC, conductivity and bioburden allows for focus on bioburden growth and biofilm formation prevention, which reduces cost and effort and ensures control of the water system for higher quality output.

This presentation covers the evolving requirements around pharmaceutical water monitoring, the need for more accurate proactive monitoring capabilities for better process control, and how to adapt these newer technologies while adhering to stringent regulations.

Presenter Information

Jim Cannon is Head of OEM and Markets at Mettler-Toledo Thornton. After receiving a B.S. in Biology, he continued with graduate degrees in Microbiology and Biophysics, and an MBA in Marketing and International Management. Cannon has over 35 years of experience in the management, design and development of ultrapure water treatment and technology. This includes measuring differential conductivity and UV oxidation for the detection of TOC in UPW and the design and commercialization of electrodeionisation modules.

Cannon is currently involved in the standards and regulatory organizations for the Semiconductor, Photovoltaic and Pharmaceutical markets, including the facilities and liquids committee, Reclaim/Reuse/Recycle Task Force and the UPW task Force. He has also involved in the development and the commercialization of alternative online microbial detection technology. He is also serving as technical advisor to several Pharmacopeia organizations and active in ISPE and PDA groups.